Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Spada

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 5, 2016
Prediction of Vertebral Fractures in Patients With Monolateral Adrenal IncidentalomasValentina Morelli, Cristina Eller-Vainicher, Serena Palmieri, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2012
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiencyClaudia Giavoli, Eriselda Profka, Elisa Verrua, et al.
The Journal of Clinical Endocrinology and Metabolism|January 20, 2012
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophsErika Peverelli, Giovanna Mantovani, Eleonora Vitali, et al.
Hormones (Athens, Greece)|April 12, 2014
Diagnostic features and outcome of surgical therapy of acromegalic patients: experience of the last three decadesElisa Sala, Emanuele Ferrante, Marco Locatelli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2009
Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severityCristina Eller-Vainicher, Iacopo Chiodini, Claudia Battista, et al.
Frontiers in Endocrinology|June 20, 2022
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary CellsFederica Mangili, Emanuela Esposito, Donatella Treppiedi, et al.
Endocrine-Related Cancer|June 4, 2021
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophsDonatella Treppiedi, Genesio Di Muro, Giusy Marra, et al.
Hormones (Athens, Greece)|February 21, 2013
Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders?Emanuele Ferrante, Valentina Morelli, Claudia Giavoli, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2014
Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiationElena Malchiodi, Eriselda Profka, Emanuele Ferrante, et al.
European Journal of Endocrinology|June 27, 2014
Factors associated with vertebral fracture risk in patients with primary hyperparathyroidismCristina Eller-Vainicher, Claudia Battista, Vito Guarnieri, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|May 5, 2016
Prediction of Vertebral Fractures in Patients With Monolateral Adrenal IncidentalomasValentina Morelli, Cristina Eller-Vainicher, Serena Palmieri, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2012
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiencyClaudia Giavoli, Eriselda Profka, Elisa Verrua, et al.
The Journal of Clinical Endocrinology and Metabolism|January 20, 2012
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophsErika Peverelli, Giovanna Mantovani, Eleonora Vitali, et al.
Hormones (Athens, Greece)|April 12, 2014
Diagnostic features and outcome of surgical therapy of acromegalic patients: experience of the last three decadesElisa Sala, Emanuele Ferrante, Marco Locatelli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2009
Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severityCristina Eller-Vainicher, Iacopo Chiodini, Claudia Battista, et al.
Frontiers in Endocrinology|June 20, 2022
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary CellsFederica Mangili, Emanuela Esposito, Donatella Treppiedi, et al.
Endocrine-Related Cancer|June 4, 2021
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophsDonatella Treppiedi, Genesio Di Muro, Giusy Marra, et al.
Hormones (Athens, Greece)|February 21, 2013
Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders?Emanuele Ferrante, Valentina Morelli, Claudia Giavoli, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2014
Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiationElena Malchiodi, Eriselda Profka, Emanuele Ferrante, et al.
European Journal of Endocrinology|June 27, 2014
Factors associated with vertebral fracture risk in patients with primary hyperparathyroidismCristina Eller-Vainicher, Claudia Battista, Vito Guarnieri, et al.
Pageof 13